Navigation Links
Synbiotics Corporation Announces Human Submission for FluDetect(R)
Date:3/13/2008

KANSAS CITY, Mo., March 13 /PRNewswire/ -- Synbiotics Corporation today announced that it is seeking 510(k) authorization from the Food & Drug Administration (FDA) for the use of its FluDetect(R) Avian Influenza Virus rapid test strip in humans. This represents Synbiotics first foray into the human point-of-care diagnostic marketplace. While it is not Synbiotics' initial intent to market this product itself to the human field, it is actively seeking an established strategic human diagnostic partner, to market, sell and distribute this product.

Currently, the FluDetect(R) product is the only USDA approved rapid point of care test for avian influenza in the veterinary field. FluDetect(R) has been heralded for its extreme sensitivity in a simple to use test format that requires no equipment, nor extensive training to perform. Management believes this may be the first crossover test to be licensed for use both in humans and animals and can be a vital tool to healthcare institutions for both seasonal flu testing as well as in endemic situations.

"The feedback we have received on the outstanding field performance of FluDetect(R) in avian influenza has encouraged us to seek human use," said Paul Hays, Synbiotics' President & Chief Executive Officer. "It is our goal to find a partner in a timely fashion to be prepared to enter the human market for the 2008-2009 flu season," said Hays. Inquiries by potential partners should be made to Ronan Molloy at ronanm@synbiotics.com.

Synbiotics Corporation develops, manufactures and markets veterinary diagnostic products for the poultry, livestock and companion animal markets worldwide. Synbiotics is an expert in avian influenza surveillance and early detection. Synbiotics manufactures and distributes its products through its operations in San Diego, California, and Lyon, France. For information on Synbiotics and its products, visit the Company's website at '/>"/>

SOURCE Synbiotics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones
2. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
3. CEL-SCI Corporation Reports First Quarter Financial Results
4. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
5. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
6. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
7. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
8. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
9. CEL-SCI Corporation Announces 2007 Financial Results
10. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire...e that predict a high likelihood of relapse in chi...hough the researchers caution that further researc...called IKZF1 or IKAROS, lead to leukemia relap...or future diagnostic tests to assess the risk of t...
(Date:1/7/2009)..., OXFORD, England, January 7 /PRNewswire/ -...mpany focused on allergy and critical care, today,...lts achieved in 2008 with,its ToleroMune(R) anti-...,patient recruitment for a further phase II clinic...rway in Canada, has recruited 120 patients with co...
(Date:1/6/2009)..., ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswire...tical company focused on diseases of epidemic pote...andidate for the treatment of tuberculosis (TB), w...ly awarded clinical program contract to Dynport Va... contract, awarded by the National Institute of Al...
(Date:1/5/2009)..., BETHESDA, Md., Jan. 5 /PRNewswire-FirstCa...rmaceutical company developing novel, proprietary,...ion and autoimmune diseases,provides an outlook ..., Micromet intends to provide an update on its...ng events: , -- April 12 to 16, 2009: Updat...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Childhood Obesity May Be Leveling Off 20322 1Childhood Obesity May Be Leveling Off 20322 2Childhood Obesity May Be Leveling Off 20322 31 small step for a lab science 1 green leap for mankind 20320 11 small step for a lab science 1 green leap for mankind 20320 2Berkeley Premium Nutraceuticals Pushes Forward 20318 1Ohio Association of Health Plans Names Pinnacle Awards to Programs That Improve Health Care for Ohioans 20316 1Ohio Association of Health Plans Names Pinnacle Awards to Programs That Improve Health Care for Ohioans 20316 2
...cal data on leading,drug-eluting stent portfolio, ... -- Boston,Scientific Corporation today announced ...ss announcements at the annual Paris,Course on Rev... 22,to 25 in Barcelona, Spain. , "We will be annou... and registries, adding to the knowledge base for ...
...y 15, 2007 - Synthetic Blood,International, Inc. (...tatistical analysis of its Phase IIa study with Ox... In line with preliminary,study results announced ...at the primary endpoint of increasing patients, ox.... Data also show a,decrease in patient glucose and...
Other Medicine Technology:Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3
(Date:1/8/2009)...RNewswire/ -- New York City Mayor Michael R. Bloom...on Day" and presented a proclamation to Ilchi Lee,... Association) and developer of Brain Education, a ...nce health, well-being, and mental ability for all... regarding the power of individuals to change them...
(Date:1/8/2009)...n. 8 Today, the Nationa...ith several national leadership organizations issu...of hospice care and protection of the Medicare Hos...in sharing this unified message about end-of-life ...alliative Medicine, Hospice and Palliative Nurses ...
(Date:1/8/2009)...tting on the surface of cancer cells are keys to t...ting and stopping the spread of certain types of c...breast, ovarian and lung, among others. Armed wit...ay for Cancer Research, an Illinois-based philanth...M.D., Ph.D., and her co-workers at the Moores Canc...
(Date:1/8/2009)...atal Solution Key Factor in Decision for Florida M...Fla., Jan. 8 Allscripts ... of the largest multi-specialty group practices in...scripts Enterprise(TM) Electronic Health Record (E... 18 offices across Central Florida. , , (Logo...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
...e British Medical Journal has noted that there has...ight individuals in China.//China now accounts for...tion. Factors like changes in food habits, change...tivity have been attributed to being responsible f...
...euk Nursery Centre in Wishaw is recovering at home... of the E.coli O157 infection. The Craigneuk Nur...ther cases have been reported. A NHS Lanarkshire...al the child's age or sex, said all staff and pare...
...llah Khan is grateful to Prime Minister Manmohan S...or his treatment//, but is pained that the central...cooking gas agency for one of his grandsons. The ...Bharat Ratna - India's highest civilian honour - i...
...Walsall, was wrongly diagnosed with stomach cancer...ved. Much later, it was found out that the hospita...had only a benign tumor. The operation was carried...Hospital. The pathologist responsible for this mis...
Other Medicine News:Health News:Bismillah Khan frets over government ignoring request 2
...he first objective measurement for CHF. Blood test...diac hormone produced by the heart ventricles in r...re overload. Excellent hormonal marker of ventricu... BNP Test provides meaningful diagnostic informati...
...alvage System offers five different products for l...ese components are cobalt-chrome, ultra high molec...AN products are extensions of Wright Medical Techn... , ,The distal femur consists of a rotating hinge ...
The MOST Options System is designed to enable patients facing severe bone loss of the knee or hip to regain use of their limbs and provides the potential for restoration of function. , ,The system go
...System (OSS) from Biomet Inc. offers the most comp... specifically for orthopaedic surgeons and oncolog...ir patients: significant bone loss, ligamentous de...throplasties, and multiple hip revision arthroplas...
Medicine Products: